A FRET-based Biosensor for Targeting the hNTH1-YB1 Interface as a Potential Anti-Cancer Drug Target

ACS Chemical Biology - United States
doi 10.1021/acschembio.9b01023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Arsenic Sulfide as a Potential Anti-Cancer Drug

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Ellagic Acid as a Potential Anti-Cancer Drug

International Journal of Radiology & Radiation Therapy
2017English

Mammaglobin as a Potential Molecular Target for Breast Cancer Drug Delivery

Cancer Cell International
Cancer ResearchOncologyGenetics
2009English

The TWEAK-Fn14 System as a Potential Drug Target

British Journal of Pharmacology
Pharmacology
2013English

Human Recombinant RNASET2: A Potential Anti-Cancer Drug

Oncoscience
Cancer ResearchOncology
2016English

Matrix Metalloproteinase9 as the Protein Target in Anti-Breast Cancer Drug Discovery: An Approach by Targeting Hemopexin Domain

Future Journal of Pharmaceutical Sciences
2019English

ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy

Current Protein and Peptide Science
MedicineBiochemistryCell BiologyMolecular Biology
2018English

CDK4 as a Phytochemical Based Anticancer Drug Target

2019English

A Meta-Analysis for CXCR4 as a Prognostic Marker and Potential Drug Target in Non-Small Cell Lung Cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy